Answers are grounded in this paper and cite their sources.
To overcome glutathione-induced malignant potential of pancreatic ductal adenocarcinoma (PDAC), redox-responsive nanoparticles based on glutathione depletion strategy were used to deliver histone methyltransferase G9a inhibitor for PDAC therapy.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: